Shu Song

420 total citations
22 papers, 288 citations indexed

About

Shu Song is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shu Song has authored 22 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Shu Song's work include Peptidase Inhibition and Analysis (5 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Shu Song is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Shu Song collaborates with scholars based in China, Venezuela and Australia. Shu Song's co-authors include Haicheng Tang, Luyong Zhang, Hong Liao, Jing Sun, Jun Yan, Yinquan Fang, Hongqi Liu, Jing‐Jing Guo, M Matsutani and Jinbo Liu and has published in prestigious journals such as Brain Research, Frontiers in Immunology and Journal of Leukocyte Biology.

In The Last Decade

Shu Song

20 papers receiving 282 citations

Peers

Shu Song

ONCOL

IMMUN

PHARM

Mengdan Yan China

Jinghui Liang China

Jiamin Zhou China

Weisong Cai China

Mascha Koenen Germany

Dong‐Hyuk Sheen South Korea

Parween Abdulla Canada

Eugene A. Berkowitz United States

B. L. Park South Korea

Anna S. Wilhelmson Sweden

Mengdan Yan China

Shu Song

154 ×1.3

51 ×0.8

ONCOL

87 ×1.4

45 ×1.1

IMMUN

28 ×0.9

PHARM

Citations per year, relative to Shu Song Shu Song (= 1×) peers Mengdan Yan

Countries citing papers authored by Shu Song

Since Specialization

Citations

This map shows the geographic impact of Shu Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Song more than expected).

Fields of papers citing papers by Shu Song

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Song. The network helps show where Shu Song may publish in the future.

Co-authorship network of co-authors of Shu Song

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Song. A scholar is included among the top collaborators of Shu Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Song. Shu Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhuang, Jiabao, Shu Song, Quan Pan, et al.. (2025). NIR‐II Type I Photosensitizer for Efficient Cancer Therapy Through Synergistic Ferroptosis/Pyroptosis Induction and Mitophagy Inhibition. Advanced Healthcare Materials. 14(23). e2501346–e2501346.

Song, Shu, et al.. (2024). EMP3: A promising biomarker for tumor prognosis and targeted cancer therapy. Cancer Biomarkers. 40(3-4). 227–239.

Wang, Fei, Jing Zhou, Duoduo Li, et al.. (2024). Mycobacterial CpsA activates type I IFN signaling in macrophages via cGAS-mediated pathway. iScience. 27(5). 109807–109807. 1 indexed citations

Wen, Zilu, Lin Wang, Hui Ma, et al.. (2024). Integrated single-cell transcriptome and T cell receptor profiling reveals defects of T cell exhaustion in pulmonary tuberculosis. Journal of Infection. 88(6). 106158–106158. 9 indexed citations

Song, Shu, et al.. (2023). circANKRD28 inhibits cisplatin resistance in non‐small‐cell lung cancer through the miR‐221‐3p/SOCS3 axis. The Journal of Gene Medicine. 25(4). e3478–e3478. 13 indexed citations

Zeng, Dong, Jianxin Liu, Duoduo Li, et al.. (2023). Temporal and cellular analysis of granuloma development in mycobacterial infected adult zebrafish. Journal of Leukocyte Biology. 115(3). 525–535. 2 indexed citations

Song, Shu, et al.. (2022). LncRNA BCYRN1 promotes cell migration and invasion of non-small cell lung cancer via the miR-30b-3p/ROCK1 axis. Neoplasma. 69(3). 583–593. 4 indexed citations

Xie, Lingling, Kaile Zhang, Yu Tian, et al.. (2022). Negative Regulator Nlrc3-like Maintain the Balanced Innate Immune Response During Mycobacterial Infection in Zebrafish. Frontiers in Immunology. 13. 893611–893611. 14 indexed citations

Feng, Yanling, Zhenyan Wang, Dong Zeng, et al.. (2022). High expression of HIV-1 matrix protein p17 in both lymphoma and lymph node tissues of AIDS patients. Pathology - Research and Practice. 237. 154061–154061. 4 indexed citations

10.

Song, Shu, Haicheng Tang, Wenqiang Quan, Anquan Shang, & Chunhua Ling. (2022). Estradiol initiates the immune escape of non-small cell lung cancer cells via ERβ/SIRT1/FOXO3a/PD-L1 axis. International Immunopharmacology. 107. 108629–108629. 19 indexed citations

11.

Tang, Haicheng, Pei Pang, Qin Zhu, et al.. (2021). The CPNE Family and Their Role in Cancers. Frontiers in Genetics. 12. 689097–689097. 21 indexed citations

12.

Wang, Li, Jian Wu, Shu Song, et al.. (2021). Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma. Frontiers in Oncology. 11. 625109–625109. 42 indexed citations

13.

Feng, Yanling, Dong Zeng, Shu Song, et al.. (2021). Case report: histopathology and molecular pathology analysis on enteric tissue of a COVID-19 patient. Diagnostic Pathology. 16(1). 40–40. 5 indexed citations

14.

Zhang, Xiuqin, Weiguo Xie, Zhiqiang Wang, et al.. (2020). Expression of a novel immune checkpoint B7-H6 ligand in human small cell lung cancer. Annals of Translational Medicine. 8(9). 589–589. 11 indexed citations

15.

Zhang, Xiuqin, et al.. (2020). Effective combined therapy for pulmonary epithelioid hemangioendothelioma: A case report. World Journal of Clinical Cases. 8(10). 2009–2015. 5 indexed citations

16.

Zhang, Xiuqin, et al.. (2020). The significance of immune-regulatory molecule B7-H4 in small cell lung cancer. Annals of Palliative Medicine. 9(4). 1953–1957. 1 indexed citations

17.

Sun, Jing, Yinquan Fang, Tao Chen, et al.. (2012). WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination. Brain Research. 1491. 225–235. 28 indexed citations

18.

Liu, Hongqi, et al.. (2012). HER-2/neu and TOPIIα Expression in Gastric Cancer Reflect Disease Severity. Hepatogastroenterology. 59(116). 1290–3. 5 indexed citations

19.

Sun, Jing, Yinquan Fang, Tao Chen, et al.. (2012). WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats. Acta Pharmacologica Sinica. 34(1). 119–128. 33 indexed citations

20.

Liu, Hongqi, et al.. (2011). Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its clinical significance. Oncology Letters. 2(6). 1319–1322. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact